These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23267148)
21. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252 [TBL] [Abstract][Full Text] [Related]
22. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer. Liu Y; Gao X; Deeb D; Arbab AS; Gautam SC Molecules; 2012 Dec; 17(12):14795-809. PubMed ID: 23519253 [TBL] [Abstract][Full Text] [Related]
23. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway. Ray DM; Morse KM; Hilchey SP; Garcia TM; Felgar RE; Maggirwar SB; Phipps RP; Bernstein SH Exp Hematol; 2006 Sep; 34(9):1202-11. PubMed ID: 16939813 [TBL] [Abstract][Full Text] [Related]
25. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284 [TBL] [Abstract][Full Text] [Related]
26. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma. Gao X; Deeb D; Liu Y; Liu P; Zhang Y; Shaw J; Gautam SC Int J Oncol; 2015 Dec; 47(6):2100-6. PubMed ID: 26497549 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity. Deeb D; Gao X; Liu Y; Kim SH; Pindolia KR; Arbab AS; Gautam SC Biochem Biophys Res Commun; 2012 Jun; 422(4):561-7. PubMed ID: 22609405 [TBL] [Abstract][Full Text] [Related]
28. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer. Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762 [TBL] [Abstract][Full Text] [Related]
29. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580 [TBL] [Abstract][Full Text] [Related]
30. c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells. Zou W; Chen S; Liu X; Yue P; Sporn MB; Khuri FR; Sun SY Cancer Biol Ther; 2007 Oct; 6(10):1614-20. PubMed ID: 18253090 [TBL] [Abstract][Full Text] [Related]
31. Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells. Qin DJ; Tang CX; Yang L; Lei H; Wei W; Wang YY; Ma CM; Gao FH; Xu HZ; Wu YL PLoS One; 2015; 10(7):e0132337. PubMed ID: 26134508 [TBL] [Abstract][Full Text] [Related]
32. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells. Qin D; Wang W; Lei H; Luo H; Cai H; Tang C; Wu Y; Wang Y; Jin J; Xiao W; Wang T; Ma C; Xu H; Zhang J; Gao F; Wu YL Oncotarget; 2016 Nov; 7(47):77096-77109. PubMed ID: 27780924 [TBL] [Abstract][Full Text] [Related]
33. Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179. Ahmad R; Raina D; Meyer C; Kharbanda S; Kufe D J Biol Chem; 2006 Nov; 281(47):35764-9. PubMed ID: 16998237 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells. Gibellini L; Pinti M; Bartolomeo R; De Biasi S; Cormio A; Musicco C; Carnevale G; Pecorini S; Nasi M; De Pol A; Cossarizza A Oncotarget; 2015 Sep; 6(28):25466-83. PubMed ID: 26314956 [TBL] [Abstract][Full Text] [Related]
35. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. Stadheim TA; Suh N; Ganju N; Sporn MB; Eastman A J Biol Chem; 2002 May; 277(19):16448-55. PubMed ID: 11880365 [TBL] [Abstract][Full Text] [Related]
36. Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. Akuetteh PDP; Huang H; Wu S; Zhou H; Jin G; Hong W; Yang H; Lan L; Shangguan F; Zhang Q J Biochem Mol Toxicol; 2022 Nov; 36(11):e23192. PubMed ID: 35929395 [TBL] [Abstract][Full Text] [Related]
37. Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells. Jeong SA; Kim IY; Lee AR; Yoon MJ; Cho H; Lee JS; Choi KS Oncotarget; 2015 Aug; 6(25):21173-92. PubMed ID: 26053096 [TBL] [Abstract][Full Text] [Related]
38. Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer. Gao X; Deeb D; Liu Y; Arbab AS; Divine GW; Dulchavsky SA; Gautam SC Cancers (Basel); 2011; 3(3):3353-69. PubMed ID: 21961053 [TBL] [Abstract][Full Text] [Related]
39. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-кB/mTOR prosurvival signaling. Deeb D; Gao X; Liu Y; Zhang Y; Shaw J; Valeriote FA; Gautam SC Int J Oncol; 2016 Sep; 49(3):1139-47. PubMed ID: 27573873 [TBL] [Abstract][Full Text] [Related]
40. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Konopleva M; Tsao T; Ruvolo P; Stiouf I; Estrov Z; Leysath CE; Zhao S; Harris D; Chang S; Jackson CE; Munsell M; Suh N; Gribble G; Honda T; May WS; Sporn MB; Andreeff M Blood; 2002 Jan; 99(1):326-35. PubMed ID: 11756188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]